- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02320344
Partnerships to Improve Lifestyle Interventions (PILI) 'Ohana Dissemination Project Partners in Care
May 1, 2018 updated by: Joseph Keawe'aimoku Kaholokula, University of Hawaii
The 3-month face-to-face Partners in Care intervention will be community-based and community-led by trained community peer educators from these four partnering community organizations.
The intervention involves 12 weekly, group lessons with each lesson lasting about 1 and 1/2 hours.
Individuals with a hemoglobin A1c (HbA1c; average blood sugar levels) greater than or equal to 7% will be recruited for the study because they represent the most at-risk for diabetes-related complications.
Over a 3-year accrual period, the community partners will recruit and enroll 150 eligible NHs and PPs, as well as deliver and evaluate the intervention in their respective community settings.
The primary outcomes of our study are hemoglobin A1c and self-reported diabetes specific quality of life.
Secondary outcomes are cholesterol levels (including HDL, LDL, total cholesterol, and triglycerides), blood pressure, body mass index, and psychosocial adaptation.
Study Overview
Study Type
Interventional
Enrollment (Actual)
47
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Hawaii
-
Honolulu, Hawaii, United States, 96813
- Department of Native Hawaiian Health, University of Hawaii
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Adults age >18 years of age,
- English-speaking,
- Physician-diagnosed type 2 diabetes, and
- Baseline hemoglobin A1c >7%.
Exclusion Criteria:
- Survival less than 6 months,
- Planning to move out of the community during the intervention study period,
- Pregnancy,
- Any co-morbid condition (physical and mental disabilities) that would prevent the individual from participating in the intervention protocol (i.e., major psychiatric illness).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Partners in Care
|
The diabetes self-management intervention is titled, "Partners in Care," emphasizing that there are many individuals and groups that one can call upon to assist with managing one's diabetes.
The content includes practical behavioral strategies to improve diabetes self-management practices.
The 12 week curriculum provides a basic overview of diabetes and self-management activities, standards of care recommended by the American Diabetes Association, strategies to improve patient-provider communication, support needed for diabetes self-management, information about diabetes medications, and ways to avoid diabetes-related complications.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hemoglobin A1c
Time Frame: 3 months
|
change in hemoglobin A1c from baseline to 3-months
|
3 months
|
Problem Areas in Diabetes
Time Frame: 3 months
|
The Problem Areas in Diabetes (PAID) will be used to assess diabetes specific quality of life.
Change in PAID score from baseline to 3-months
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Total Cholesterol (including HDL and LDL)
Time Frame: 3 months
|
change in cholesterol from baseline to 3 months
|
3 months
|
Triglycerides
Time Frame: 3 months
|
change in triglycerides from baseline to 3 months
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2013
Primary Completion (Actual)
December 1, 2017
Study Completion (Actual)
December 1, 2017
Study Registration Dates
First Submitted
December 16, 2014
First Submitted That Met QC Criteria
December 16, 2014
First Posted (Estimate)
December 19, 2014
Study Record Updates
Last Update Posted (Actual)
May 3, 2018
Last Update Submitted That Met QC Criteria
May 1, 2018
Last Verified
October 1, 2017
More Information
Terms related to this study
Other Study ID Numbers
- MD001660 - PIC
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 2 Diabetes
-
Antonio Di MauroCompletedType-2 DiabetesItaly
-
DiaMedica Therapeutics IncCompletedDiabetes Type 2Netherlands
-
RenJi HospitalUnknownType 2 Diabetes.China
-
Chengdu Brilliant Pharmaceutical Co., Ltd.Not yet recruitingType 2 Diabetes Mellitus
-
Nanjing First Hospital, Nanjing Medical UniversityRecruitingType 2 Diabetes MellitusChina
-
Xiangya Hospital of Central South UniversityRecruitingType 2 Diabetes MellitusChina
-
University of Alabama at BirminghamCompletedType 2 Diabetes MellitusUnited States
-
Imperial College LondonAstraZeneca; Huma; North West London Collaboration of CCGs (NWL CCGs); Imperial...CompletedType 2 Diabetes MellitusUnited Kingdom
-
Universiti Sains MalaysiaCompleted
-
University of Alabama at BirminghamUnited States Department of Defense; Loma Linda University; Brenda Davis Nutrition... and other collaboratorsCompletedType 2 Diabetes Mellitus
Clinical Trials on Partners in Care
-
University of HawaiiNational Institute on Minority Health and Health Disparities (NIMHD)Completed
-
University of HawaiiNational Institute on Minority Health and Health Disparities (NIMHD)Completed
-
VA Office of Research and DevelopmentAlzheimer's Association; Benjamin Rose InstituteCompletedDementia | Alzheimer DiseaseUnited States
-
University of NebraskaNational Institute of Nursing Research (NINR)CompletedCoronary Heart Disease | Cardiac RehabilitationUnited States
-
VA Office of Research and DevelopmentUniversity of Michigan; Michigan State UniversityCompletedCancerUnited States
-
New York State Psychiatric InstituteNational Institute of Mental Health (NIMH)CompletedAutism Spectrum DisorderUnited States
-
Dartmouth-Hitchcock Medical CenterCignaCompletedCaregiver StressUnited States
-
Health Quality PartnersCenters for Medicare and Medicaid ServicesUnknownHeart Failure | Coronary Disease | Hypertension | Diabetes Mellitus | Asthma | HypercholesterolemiaUnited States
-
University of WashingtonWashington State University; American Diabetes Association; DexCom, Inc.; Sea Mar...RecruitingDiabetes Type 2United States
-
University of Alabama at BirminghamNational Cancer Institute (NCI)RecruitingCancer | Family MembersUnited States